The first approved classification of medulloblastomas concerning the molecular characteristics was performed by the WHO in 2016, resulting in four different molecular groups of MBs, each of which has a totally different molecular signature from both genetic and epigenetic aspects: WNT (wingless-related integration site) activated, SHH (sonic hedgehog)- activated, Group 3, and Group 4 [16,17,63]. The gene discussed is SHH; the disease is Mobius syndrome.